France's Sanofi Expands mRNA Vaccine Drive With US Firm Purchase
3 years, 4 months ago

France's Sanofi Expands mRNA Vaccine Drive With US Firm Purchase

News 18  

France’s pharmaceutical giant Sanofi, which has lagged behind rivals in developing new generation mRNA Covid-19 vaccines, on Tuesday said it has purchased a US firm specialising in the technology. Sanofi was left trailing in the race to break out a Covid-19 vaccine in 2020, as rivals Pfizer-BioNTech and Moderna used pioneering mRNA technology to develop jabs in record time. Sanofi, which has been working on developing an mRNA vaccine with Translate Bio, based in Lexington, Massachusetts, said it was betting on the new technology beyond the coronavirus pandemic. Germany’s BioNTech, which developed the coronavirus vaccine with US giant Pfizer, announced in July that it aimed to start trialling a malaria vaccine using the mRNA breakthrough technology.

Technology Vaccine Mrna Sanofi Firm Purchase  mrna  expands  billion  working  sanofi  translate  firm  purchase  drive  vaccine  developing  vaccines  coronavirus  traditional  frances  technology

History of this topic

New push for mRNA bird flu vaccine development: WHO
4 months, 3 weeks ago

New push for mRNA bird flu vaccine development: WHO

The Hindu  

The World Health Organisation announced Monday, July 29, 2024, a new project to accelerate the development in poorer countries, of vaccines for human bird flu infections, using cutting-edge messenger RNA technology. Vaccine equity Swiftly developed mRNA Covid vaccines were game-changers during the pandemic, but they also exposed glaring global vaccine inequity and demands for a fairer distribution amid efforts to …

Gates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming years
1 year, 2 months ago

Gates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming years

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy A $40 million investment will …

The trouble with a Nobel for mRNA COVID vaccines
1 year, 2 months ago

The trouble with a Nobel for mRNA COVID vaccines

The Hindu  

The 2023 Nobel Prize for Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for developing the mRNA vaccine technology that became the foundation for history’s fastest vaccine development programme during the COVID-19 pandemic. Once Moderna and Pfizer began producing their mRNA COVID-19 vaccines, they were also mired in North American and European countries’ zeal to make …

Years of research laid the groundwork for speedy COVID-19 shots
1 year, 2 months ago

Years of research laid the groundwork for speedy COVID-19 shots

Associated Press  

The Nobel Prize in Medicine was awarded Monday to two scientists whose work led to the mRNA vaccines against COVID-19. “Abject giddiness,” is how Dr. C. Buddy Creech, a Vanderbilt University vaccine expert, described scientists’ reactions when separate studies showed the two candidates were about 95% effective. Billions in company and government funding certainly sped up vaccine development — and …

Scientists whose work on mRNA paved the way for first COVID-19 vaccines win Nobel Prize
1 year, 2 months ago

Scientists whose work on mRNA paved the way for first COVID-19 vaccines win Nobel Prize

LA Times  

Dr. Drew Weissman, left, a physician-scientist, and biochemist Katalin Karikó won the Nobel Prize in medicine for discoveries that enabled the creation of mRNA vaccines against COVID-19 and that could be used to develop other shots in the future. “This year’s Nobel Prize recognizes their basic science discovery that fundamentally changed our understanding of how mRNA interacts with the immune …

How vaccines helped reshape the course of the Covid-19 pandemic
1 year, 3 months ago

How vaccines helped reshape the course of the Covid-19 pandemic

Hindustan Times  

When future generations look back at the pandemic, they will deem it a black swan event. Let’s delve deep into the crucial role vaccines played in the fight against COVID-19, highlighting their significance in preventing infections, crucial collaborations, the emergence of mRNA as the next big revolution in the vaccine space and more. mRNA vaccines represent a ground-breaking technology that …

Moderna sues Pfizer/BioNTech for patent infringement over COVID-19 vaccine
2 years, 3 months ago

Moderna sues Pfizer/BioNTech for patent infringement over COVID-19 vaccine

The Hindu  

Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. The U.S. Food and Drug Administration granted emergency use authorization for the COVID-19 vaccine first to Pfizer/BioNTech in December 2020, then one week later …

Moderna Sues Pfizer, BioNTech For Patent Infringement Over Its mRNA Covid Vaccine
2 years, 3 months ago

Moderna Sues Pfizer, BioNTech For Patent Infringement Over Its mRNA Covid Vaccine

ABP News  

Moderna said on Friday it was suing Pfizer and and its German partner BioNTech for copying the "groundbreaking technology" behind its mRNA Covid-19 vaccine. "Moderna believes that Pfizer and BioNTech's Covid-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology," the company said in a statement. "Moderna expects Pfizer and BioNTech to compensate Moderna …

Moderna Sues Pfizer, BioNTech for Covid-19 Vaccine Patent Infringement
2 years, 3 months ago

Moderna Sues Pfizer, BioNTech for Covid-19 Vaccine Patent Infringement

News 18  

Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot that has been administered to hundreds of millions around the world. “Moderna believes that Pfizer and BioNTech’s Covid-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna’s foundational mRNA technology,” the company said …

Moderna sues Pfizer, BioNTech for Covid-19 vaccine patent infringement
2 years, 3 months ago

Moderna sues Pfizer, BioNTech for Covid-19 vaccine patent infringement

India Today  

Moderna said on Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot administered to hundreds of millions around the world. "Moderna believes that Pfizer and BioNTech's Covid-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology," the US-based biotech firm said …

Moderna sues Pfizer, BioNTech for patent infringement over Covid-19 vaccine
2 years, 3 months ago

Moderna sues Pfizer, BioNTech for patent infringement over Covid-19 vaccine

Live Mint  

American pharmaceutical and biotechnology company Moderna has filed a suit in a United States District court against Pfizer and its German partner BioNTech, seeking undetermined damages for patent infringement in the development of the first Covid-19 vaccine. Moderna in a press release informed that they are seeking undetermined monetary damages in the lawsuit filed in the U.S. District Court in …

Moderna sues rival COVID-19 vaccine makers Pfizer and BioNTech
2 years, 3 months ago

Moderna sues rival COVID-19 vaccine makers Pfizer and BioNTech

Al Jazeera  

Moderna previously pledged not to enforce COVID-19-related patents but changed its stance as the pandemic shifted gears. Moderna has said it is suing rival vaccine maker Pfizer and its German partner BioNTech, citing infringement on its patents in developing the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. “Moderna …

Will Americans have the right COVID-19 vaccine this fall? Maybe
2 years, 5 months ago

Will Americans have the right COVID-19 vaccine this fall? Maybe

LA Times  

A man walks underneath the marquee of the Alex Theatre in Glendale. Determining which recipe should go into those doses to induce optimal protection — the vaccine’s “composition” — is an exercise in educated guesswork. Getting a timely and accurate fix on all this “is truly a challenge, and it is science at its hardest,” Dr. Peter Marks, the U.S. …

China’s bet on homegrown mRNA vaccines holds back nation
2 years, 7 months ago

China’s bet on homegrown mRNA vaccines holds back nation

Associated Press  

TAIPEI, Taiwan — China is trying to navigate its biggest coronavirus outbreak without a tool it could have adopted many months ago, the kind of vaccines that have proven to offer the best protection against the worst outcomes from COVID-19. “The consequences will be huge, the supply chain disruption, the disruption to all kinds of service sectors.” Studies have consistently …

China’s insistence on a homegrown mRNA vaccine haunts its COVID-control efforts
2 years, 7 months ago

China’s insistence on a homegrown mRNA vaccine haunts its COVID-control efforts

LA Times  

China’s first homegrown mRNA COVID-19 vaccine has yet to undergo all the necessary trials before use. “The consequences will be huge — the supply-chain disruption, the disruption to all kinds of service sectors.” Studies have consistently shown that vaccination with mRNA vaccines made by Pfizer-BioNTech and Moderna offer the best protection against hospitalization and death from COVID-19. The Communist Party-owned …

Hyderabad-based CCMB announces first potential mRNA COVID vaccine
2 years, 7 months ago

Hyderabad-based CCMB announces first potential mRNA COVID vaccine

Firstpost  

Dr N Madhusudan Rao, CEO of Atal Incubation Centre at Centre for Cellular and Molecular Biology, said the mRNA platform has an advantage of flexibility unlike other vaccine platforms New Delhi: Dr N Madhusudan Rao, CEO-Atal Incubation Centre at Centre for Cellular and Molecular Biology on Monday said that India has developed mRNA technology against the COVID-19. The Hyderabad-based Centre …

India develops first mRNA vaccine technology to fight Covid-19
2 years, 7 months ago

India develops first mRNA vaccine technology to fight Covid-19

India Today  

India’s first indigenous mRNA vaccine technology to fight against Covid-19 has been developed by the Centre for Cellular and Molecular Biology and Council Of Scientific And Industrial Research. CSIR-Centre for Cellular and Molecular Biology is leading the development of mRNA vaccine technology in India. However, we lack the potent mRNA vaccine technology, as developed by Moderna or Pfizer/BioNtech to combat …

Hyderabad-based manufacturer to get mRNA technology from WHO to produce COVID-19 vaccines
2 years, 8 months ago

Hyderabad-based manufacturer to get mRNA technology from WHO to produce COVID-19 vaccines

Firstpost  

WHO and their partners will work with the Indian government to develop a roadmap and put in place the necessary training and support for Biological E to start producing mRNA vaccines as soon as possible Hyderabad: Hyderabad-based vaccine manufacturer Biological E on Monday announced that it has been selected as a recipient of mRNA technology from the World Health Organisation …

Biological E. to receive mRNA vaccine tech from WHO
2 years, 8 months ago

Biological E. to receive mRNA vaccine tech from WHO

The Hindu  

Vaccine maker Biological E. has been selected to receive mRNA technology from the World Health Organization technology transfer hub. After examining a number of proposals from India, the WHO's Advisory Committee on Vaccine Product Development has selected Biological E. as a recipient, the Hyderabad–based firm said on Monday. The company has been investing in mRNA technologies since last year and …

COVID: New protein-based vaccine up for approval
2 years, 10 months ago

COVID: New protein-based vaccine up for approval

The Hindu  

Sanofi and GlaxoSmithKline are seeking E.U. and U.S. regulatory approval of their protein-based COVID-19 vaccine, which proved 100 per cent effective at preventing severe illness in phase three clinical trials, the duo announced on Wednesday. Official trial results are yet to be published, but the companies reported that in phase three testing, two doses of the vaccine showed 100 per …

Germany’s BioNTech plans modular vaccine factories in Africa
2 years, 10 months ago

Germany’s BioNTech plans modular vaccine factories in Africa

Al Jazeera  

The first turnkey facility will be shipped to either Senegal or Rwanda in the second half of this year, BioNTech said. German vaccine maker BioNTech, which developed the first widely approved shot against COVID-19 together with Pfizer, unveiled plans Wednesday to establish manufacturing facilities in Africa that would boost the availability of much-needed medicines on the continent. “And we have, …

Africa Finds New Tool To Fight Vaccine Inequity As Afrigen Develops mRNA Covid Vaccine
2 years, 10 months ago

Africa Finds New Tool To Fight Vaccine Inequity As Afrigen Develops mRNA Covid Vaccine

News 18  

Despite the world’s major global vaccine companies refusing to share their technology, a South African vaccine manufacturer Afrigen developed its own version of mRNA COVID-19 vaccine. Afrigen used the publicly available sequence of Moderna Inc’s mRNA COVID-19 vaccine and aims to test it on humans by the end of 2022. Afrigen is a part of a consortium brought together by …

US researchers share COVID-19 vaccine with the world
2 years, 11 months ago

US researchers share COVID-19 vaccine with the world

Al Jazeera  

Using traditional technology that can be scaled widely and cheaply, Corbevax offers a potential solution to vaccine inequity. Bypassing the patent restrictions of major pharmaceutical firms, doctors Maria Elena Bottazzi and Peter Hotez at the Baylor College of Medicine and the Texas Children’s Hospital Center for Vaccine Development used traditional vaccine technology that can be deployed rapidly to help inoculate …

Africa trying to replicate Moderna's COVID vaccine in an attempt to lessen the gap of vaccine inequity
3 years, 2 months ago

Africa trying to replicate Moderna's COVID vaccine in an attempt to lessen the gap of vaccine inequity

Firstpost  

Some experts see reverse engineering — recreating vaccines from fragments of publicly available information — as one of the few remaining ways to redress the power imbalances of the pandemic. “The United States government has played a very substantial role in making Moderna the company it is,” said David Kessler, the head of Operation Warp Speed, the U.S. program to …

Africa tries to end vaccine inequity by replicating its own
3 years, 2 months ago

Africa tries to end vaccine inequity by replicating its own

Associated Press  

CAPE TOWN, South Africa — In a pair of Cape Town warehouses converted into a maze of airlocked sterile rooms, young scientists are assembling and calibrating the equipment needed to reverse engineer a coronavirus vaccine that has yet to reach South Africa and most of the world’s poorest people. “The United States government has played a very substantial role in …

Moderna has no plans to share its COVID-19 vaccine recipe
3 years, 2 months ago

Moderna has no plans to share its COVID-19 vaccine recipe

Associated Press  

ROME — Moderna has no plans to share the recipe for its COVID-19 vaccine because executives have concluded that scaling up the company’s own production is the best way to increase the global supply, the company’s chairman said Monday. In an interview with The Associated Press, Noubar Afeyan also reiterated a pledge Moderna made a year ago not to enforce …

CSIR’s Institute Plans to Seek Emergency Approval by Dec for Horse-based Antibody Therapy to Rein In Covid
3 years, 2 months ago

CSIR’s Institute Plans to Seek Emergency Approval by Dec for Horse-based Antibody Therapy to Rein In Covid

News 18  

The Hyderabad-based Centre for Cellular and Molecular Biology is planning to seek emergency-use approval for its horse-based antibody therapy for Covid treatment within the next two months, its chief told News18.com. ‘Data looks promising’ “While the cases of Covid-19 have been going down and it’s difficult to complete the trials within a stipulated time frame, we expect to submit the …

Malaria vaccine a ‘breakthrough for science’, WHO chief says
3 years, 2 months ago

Malaria vaccine a ‘breakthrough for science’, WHO chief says

Al Jazeera  

UN health body announces the Mosquirix vaccine against malaria should be widely administered to children in Africa, a move saving tens of thousands of lives. The World Health Organization said on Wednesday the only approved vaccine against malaria should be widely given to African children, marking a major advance against a disease that kills hundreds of thousands of people annually. …

AstraZeneca picks up new vaccine technology originally intended to target Covid
3 years, 3 months ago

AstraZeneca picks up new vaccine technology originally intended to target Covid

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Scientists at Imperial College London are partnering with AstraZeneca to develop …

Argentina partially reopens after weeks of declining COVID cases
3 years, 4 months ago

Argentina partially reopens after weeks of declining COVID cases

Al Jazeera  

Argentina adopted the plan after 10 consecutive weeks of lower case numbers and eight weeks of decreasing deaths. Argentina will relax coronavirus restrictions as infection and mortality rates fall, the government announced on Friday, even as the South American nation approached five million cases with more than 107,000 deaths. Given shortages of second doses of Russia’s Sputnik V vaccine, one …

Science behind Moderna vaccine: Triggering immune response against Covid-19 using mRNA
3 years, 5 months ago

Science behind Moderna vaccine: Triggering immune response against Covid-19 using mRNA

India Today  

India added one more Covid-19 vaccine to its kitty after the Drug Controller General of India granted emergency-use approval to Moderna's mRNA jab. Indian drug manufacturer Cipla has been given permission to import Moderna's Covid-19 vaccine, which will be the second foreign candidate to be approved after Russia's Sputnik V. India is also in talks with Pfizer, which has played …

EU Agency Says Covid Vaccines Like Pfizer-BioNTech and Moderna 'Promising' Against Double variant
3 years, 7 months ago

EU Agency Says Covid Vaccines Like Pfizer-BioNTech and Moderna 'Promising' Against Double variant

News 18  

Coronavirus vaccines using mRNA technology like Pfizer-BioNTech and Moderna appear able to “neutralise” the variant of Covid-19 behind India’s outbreak, the EU’s drug watchdog said on Wednesday. “The data seems to be rather reassuring on the fact that at least the messenger RNA vaccines will be able to neutralise this variant, at least to an extent that will guarantee sufficient …

BioNTech: ‘No evidence’ COVID vaccine needs adapting for variants
3 years, 7 months ago

BioNTech: ‘No evidence’ COVID vaccine needs adapting for variants

Al Jazeera  

The German company says the shot it developed with US pharmaceutical giant Pfizer does not require modifications for now. German company BioNTech has said its COVID-19 vaccine, developed in collaboration with pharmaceutical giant Pfizer, does not require modifications to protect people against key variants of the virus currently in circulation. “To date, there is no evidence that an adaptation of …

Amid AstraZeneca setback, Germany banks on homegrown vaccine
3 years, 8 months ago

Amid AstraZeneca setback, Germany banks on homegrown vaccine

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ …

COVID-19 Vaccines: The EU is at the mercy of Big Pharma
3 years, 9 months ago

COVID-19 Vaccines: The EU is at the mercy of Big Pharma

NL Times  

Stefano Valentino The vaccine business remains in the hands of the pharmaceutical industry giants. However, in addition to their own factories, pharma giants also rely on smaller, specialized companies located in several European countries. Additionally, the American company Novavax, French firm Valneva and Italy’s Reithera, with whom Brussels has already begun negotiations, will also be added to that list of …

CSL may manufacture mRNA and AstraZeneca vaccines that protect against new COVID-19 variants
3 years, 10 months ago

CSL may manufacture mRNA and AstraZeneca vaccines that protect against new COVID-19 variants

ABC  

Australia now has a second COVID-19 vaccine approved by the Therapeutic Goods Administration 9TGA). How the AstraZeneca vaccine works The AstraZeneca COVID-19 vaccine is a viral vector vaccine It enlists the help of a harmless virus, in this case a chimpanzee adenovirus ChAdOx1, to deliver a payload of genetic material into our cells The genetic material is in a ring …

Pfizer and Moderna's COVID-19 vaccines are just the beginning. Will Australia miss out on the mRNA medical revolution?
3 years, 10 months ago

Pfizer and Moderna's COVID-19 vaccines are just the beginning. Will Australia miss out on the mRNA medical revolution?

ABC  

When Drew Weissman and Katalin Karikó got their COVID-19 vaccine jabs before Christmas at the University of Pennsylvania, the cameras were rolling. They borrow a mechanism that all of your cells use to make all the proteins in your body They borrow a mechanism that all of your cells use to make all the proteins in your body They work …

Covid vaccine: Sanofi to help produce 100 million Pfizer/BioNTech vaccine doses
3 years, 10 months ago

Covid vaccine: Sanofi to help produce 100 million Pfizer/BioNTech vaccine doses

CNN  

CNN — Sanofi will fill and pack millions of doses of Pfizer’s Covid-19 vaccine from July in an effort to help meet the huge demand for the U.S. drugmaker’s shots. The French company will aim to help supply more than 100 million doses of the vaccine this year from its German plant in Frankfurt, CEO Paul Hudson told Le Figaro …

Will the coronavirus vaccines work against the new, fast-spreading UK strain?
4 years ago

Will the coronavirus vaccines work against the new, fast-spreading UK strain?

ABC  

At least four drug makers are rushing to confirm the efficacy of their COVID-19 vaccines against the new fast-spreading variant of the virus detected in the UK. Key points: The new strain of the novel coronavirus may up to 70 per cent more infectious The new strain of the novel coronavirus may up to 70 per cent more infectious But …

COVID-19 new strain in UK: Pfizer partner BioNTech ’can make a vaccine in 6 weeks if needed’
4 years ago

COVID-19 new strain in UK: Pfizer partner BioNTech ’can make a vaccine in 6 weeks if needed’

Live Mint  

German pharmaceutical company BioNTech is confident that its coronavirus vaccine will work against the mutated strain detected in Britain. "Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," said Ugur Sahin, the co-founder of BioNTech. However, "We don’t know at the moment if our vaccine is also able to …

Pfizer partner BioNTech to boost covid vaccine capacity
4 years ago

Pfizer partner BioNTech to boost covid vaccine capacity

Live Mint  

Pfizer Inc. partner BioNTech SE is pursuing all its options to make more Covid-19 vaccine doses than the 1.3 billion the companies have promised to produce next year, according to the German company’s chief executive officer. The companies will probably know by January or February whether and how many additional doses can be produced, Ugur Sahin said Monday. BioNTech is …

EU approves Pfizer-BioNTech coronavirus vaccine
4 years ago

EU approves Pfizer-BioNTech coronavirus vaccine

The Hindu  

The EU finally gave the green light for the Pfizer-BioNTech coronavirus vaccine on Monday, paving the way for the first inoculations to start across 27 countries just days after Christmas. The EMA added that the vaccine would “very likely” be effective against a new strain of the disease spreading through Britain. European Commission chief Ursula von der Leyen said vaccinations …

Lagging behind in COVID-19 vaccine race, CureVac bets on a easier to store, mass produce jab
4 years ago

Lagging behind in COVID-19 vaccine race, CureVac bets on a easier to store, mass produce jab

Firstpost  

CureVac’s product also requires a far lower dosage of just 12 micrograms, compared to 30 micrograms for BioNTech and 100 for Moderna, allowing for faster mass manufacturing. CureVac CEO Franz-Werner Haas readily admits his German biotech firm is “a bit behind” in the Covid-19 vaccine race, despite using the same cutting-edge technology as rivals Moderna and Pfizer/BioNTech. A key difference …

How were COVID-19 vaccines made so fast? Scientists had a huge head start
4 years ago

How were COVID-19 vaccines made so fast? Scientists had a huge head start

LA Times  

Blood samples from volunteers participating in tests of the COVID-19 vaccine made by Moderna and the NIH await processing in a lab. “Abject giddiness” is how Dr. C. Buddy Creech, a Vanderbilt University vaccine expert, described scientists’ reactions when separate studies showed the two candidates were about 95% effective. “They could essentially make a stealth RNA,” said Dr. Philip Dormitzer, …

Coronavirus vaccine update: Pfizer, German partner seek emergency approval, what’s next?
4 years, 1 month ago

Coronavirus vaccine update: Pfizer, German partner seek emergency approval, what’s next?

Live Mint  

At a time when we all are desperately waiting for a vaccine to curtail the spread of the novel coronavirus, the American pharmaceutical company confirmed that Pfizer Inc and its German partner BioNTech have formally asked the US Food and Drug Administration for emergency use authorisation for their Covid-19 vaccine. Here is your 10-point cheat-sheet to this story: 1) Pfizer's …

There's one big, important difference between Pfizer and Moderna's coronavirus vaccines
4 years, 1 month ago

There's one big, important difference between Pfizer and Moderna's coronavirus vaccines

Salon  

In the span of two weeks, two competing pharmaceutical companies have announced separate, promising coronavirus vaccine candidates, both of which have passed the second-to-last phase of clinical trials. Biotech giant Moderna announced earlier this week that their vaccine displayed "94.5% vaccine efficacy", while Pfizer and BioNTech SE announced similarly positive results for their vaccine candidate last week. "The current COVID-19 …

2nd coronavirus vaccine shows early success in U.S. tests
4 years, 1 month ago

2nd coronavirus vaccine shows early success in U.S. tests

The Independent  

The latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US Your briefing on the latest headlines from across the US SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy For the second time …

German Turkish Couple Who Helped Develop Pfizer's Covid-19 Vaccine Doesn't Even Own a Car
4 years, 1 month ago

German Turkish Couple Who Helped Develop Pfizer's Covid-19 Vaccine Doesn't Even Own a Car

News 18  

Scientists Ugur Sahin and Ozlem Tureci, who have dedicated their lives to finding cures for infectious diseases and cancer, helped develop the Covid-19 vaccine that is being developed by Pfizer. Positive data on BioNTech and U.S. partner Pfizer Inc’s COVID-19 vaccine is an unlikely success for the married couple behind the German biotech firm, who have devoted their lives to …

Behind Pfizer's Covid-19 vaccine, an understated husband-and-wife 'dream team'
4 years, 1 month ago

Behind Pfizer's Covid-19 vaccine, an understated husband-and-wife 'dream team'

India Today  

Positive data on BioNTech and US partner Pfizer Inc's Covid-19 vaccine is an unlikely success for the married couple behind the German biotech firm, who have devoted their lives to harnessing the immune system against cancer. From humble roots as the son of a Turkish immigrant working at a Ford factory in Cologne, BioNTech Chief Executive Ugur Sahin, 55, now …

Discover Related